Becotatug Vedotin as Adjuvant Therapy For High-risk Nasopharyngeal Carcinoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Becotatug Vedotin as Adjuvant Therapy For High-risk Nasopharyngeal Carcinoma	Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, carcinoma, epithelial neoplasm, nasopharyngeal carcinoma, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, otorhinolaryngologic disease	Not yet recruiting	Phase 2	2026-06-09		NCT07303283

15 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Affiliated Hospital of Youjiang Medical University for Nationalitie	1
Afﬁliated Hospital of North Sichuan Medical College	16
First People's Hospital of Yulin	10
Fujian Cancer Hospital	114
Guangxi Nanxishan Hospital	2
Guigang People's Hospital	4
Hainan Cancer Hospital	7
Hunan Cancer Hospital	66
Kai Hu	2
Lingshan County People's Hospital	2
LiuZhou People's Hospital	15
Liuzhou Workers' Hospital	7
the second People's Hospital of qinzhou	1
The Third people's hospital of Hechi	1
Wuzhou Red Cross Hospital	20

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The First Affiliated Hospital of Guangxi Medical University	Nanning	China	66